Sirona Technology (http://www.sironatechnology.com), a leader in driving smart customer acquisition technologies, announced today that Regenestem Network (http://www.regenestemnetwork.com) has licensed its Managed Outcome and Assessment platform to provide long-term follow-up for patients who have received investigational therapies.

Portland, Ore. (PRWEB) October 15, 2015

Sirona Technology (http://www.sironatechnology.com), a leader in driving smart customer acquisition technologies, announced today that Regenestem Network (http://www.regenestemnetwork.com) has licensed its Managed Outcome and Assessment platform to provide long-term follow-up for patients who have received investigational therapies.

”By investing in the MAO platform, Regenestem Network has advanced its leadership in the field and established its commitment to transparency, oversight and patient safety,” said David Audley, CEO and cofounder of Sirona Technology.

Sirona Technology’s MAO platform is a secure, web-based, data-driven, hosted application that provides long-term patient outcome tracking. The underlying technology of the platform allows patients to be followed according to conditions treated and therapies used. The platform produces a patient specific survey, which is delivered via a secure link by email that allows a patient to self-report results from treatments, based upon both standard complication and safety questionnaires and established, condition-specific outcome matrices.

The MAO platform was developed in cooperation with the Institute for Global Health and Research, a nonprofit advocacy and policy organization dedicated to patient education and safety.

This license with Sirona will allow the MAO platform to be deployed across the global network of trained Regenestem providers. With hundreds of physicians working in more than 10 countries, the impact will be immediate and significant. “The goal,” said Audley, “will be to allow patients to look at results from treatments that are reported by physicians, not filtered.”

“We are pleased to be the first network in the world to have this type of platform,” said Roberto De Cubas, founder and CEO of Regenestem, LLC and Regenestem Network. “At the end of the day, it is all about patient wellness and the patient data that will help the field of regenerative medicine progress. Sirona has stepped up and developed a platform that has been long overdue in the industry - and Regenestem is proud to be involved in the process of implementation.”

****

About Sirona Technology, LLC

advertisement | advertise on newsday

Located in Portland, Ore., Sirona Technology (http://www.sironatechnology.com) is a global leader delivering smart technology to drive customer acquisition. Sirona’s signature technology, CHE, is a contextual based database system that collects, aggregates and then distributes content to highly targeted web properties. Sirona provides technology and creative design and development services to multiple verticals of business with a primary focus in medicine, medical tourism and bioscience.

About Regenestem Network

Regenestem Network (http://www.regenestemnetwork.com) is the largest membership association of regenerative medicine clinics in the world, providing cutting-edge care with the latest advancements in cellular therapies to patients around the world. Regenestem Network is expanding its clinical presence worldwide by partnering with experienced and qualified regenerative medicine physicians to open new clinics, licensed and developed under the Regenestem banner.

For the original version on PRWeb visit: http://www.prweb.com/releases/2015/10/prweb13016932.htm